While this activity is likely to occur genome-wide, inhibition or ablation of CDK12 function was shown to prevalently affect expression of DDR genes and to cause DNA repair defects [11], hence sensitizing different types of cancer cells to PARPi [12, 13]. The gene discussed is CDK12; the disease is cancer.